Terug
Dagbereik
€ 72,82
€ 75,11
52-Weeksbereik
€ 60,56
€ 89,29
Volume
804.477
50D / 200D Gem.
€ 77,69
/
€ 72,09
Vorige Slotkoers
€ 74,02
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 22,0 | 0,2 |
| P/B | 2,7 | 3,0 |
| ROE % | 12,0 | 3,6 |
| Net Margin % | 3,0 | 3,8 |
| Rev Growth 5Y % | 1,5 | 9,9 |
| D/E | 1,1 | 0,2 |
Koersdoel Analisten
Hold
€ 90,17
+21.4%
Low: € 81,00
High: € 100,00
Forward K/W
14,03
Forward WPA
€ 5,29
WPA Groei (sch.)
+0,0%
Omzet Sch.
13,72B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 6,80
€ 6,75 – € 6,85
|
15,30B | 1 |
| FY2028 |
€ 6,42
€ 5,75 – € 6,93
|
14,72B | 5 |
| FY2027 |
€ 5,84
€ 5,71 – € 6,05
|
14,22B | 10 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | € 1,30 | € 1,34 | +3,1% |
| 2025-11-04 | € 1,27 | € 1,38 | +8,7% |
| 2025-08-05 | € 1,18 | € 1,10 | -6,8% |
| 2025-05-05 | € 1,11 | € 1,15 | +3,6% |
| 2025-02-25 | € 1,23 | € 1,19 | -3,3% |
| 2024-11-05 | € 1,16 | € 1,22 | +5,2% |
| 2024-08-06 | € 1,22 | € 1,23 | +0,8% |
| 2024-05-07 | € 1,02 | € 1,10 | +7,8% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 1,54% annually over 5 years — modest growth
ROE of 11,99% — decent returns on equity
Generating 573,00M in free cash flow
Cash machine — converts 143,97% of earnings into free cash flow
Capital efficient — spends only 1,05% of revenue on capex
Groei
Revenue Growth (5Y)
1,54%
Revenue (1Y)4,03%
Earnings (1Y)2,05%
FCF Growth (3Y)27,41%
Kwaliteit
Return on Equity
11,99%
ROIC8,20%
Net Margin3,02%
Op. Margin5,75%
Veiligheid
Debt / Equity
1,14
Current Ratio1,38
Interest Coverage5,05
Waardering
P/E Ratio
21,96
Forward P/E14,03
P/B Ratio2,69
EV/EBITDA16,19
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,03% | Revenue Growth (3Y) | 3,37% |
| Earnings Growth (1Y) | 2,05% | Earnings Growth (3Y) | -2,19% |
| Revenue Growth (5Y) | 1,54% | Earnings Growth (5Y) | -10,63% |
| Profitability | |||
| Revenue (TTM) | 13,18B | Net Income (TTM) | 398,00M |
| ROE | 11,99% | ROA | 3,55% |
| Gross Margin | 29,14% | Operating Margin | 5,75% |
| Net Margin | 3,02% | Free Cash Flow (TTM) | 573,00M |
| ROIC | 8,20% | FCF Growth (3Y) | 27,41% |
| Safety | |||
| Debt / Equity | 1,14 | Current Ratio | 1,38 |
| Interest Coverage | 5,05 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 21,96 | Forward P/E | 14,03 |
| P/B Ratio | 2,69 | P/S Ratio | 0,66 |
| PEG Ratio | 3,22 | Forward PEG | N/A |
| EV/EBITDA | 16,19 | Fwd EV/EBITDA | 11,62 |
| Forward P/S | 0,64 | Fwd Earnings Yield | 7,13% |
| FCF Yield | 6,56% | ||
| Market Cap | 8,74B | Enterprise Value | 12,27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13,18B | 12,67B | 12,34B | 12,65B | 12,40B |
| Net Income | 398,00M | 390,00M | 416,00M | 538,00M | 623,91M |
| EPS (Diluted) | 3,27 | 3,05 | 3,16 | 3,91 | 4,45 |
| Gross Profit | 3,84B | 3,77B | 3,65B | 3,65B | 3,67B |
| Operating Income | 758,00M | 729,00M | 714,00M | 938,00M | 854,81M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11,22B | 10,22B | 10,57B | 8,61B | 8,48B |
| Total Liabilities | 6,42B | 5,38B | 5,42B | 3,94B | 3,81B |
| Shareholders' Equity | 3,25B | 3,39B | 3,66B | 3,45B | 3,43B |
| Total Debt | 3,69B | 2,87B | 2,74B | 1,50B | 1,22B |
| Cash & Equivalents | 156,00M | 122,00M | 171,00M | 117,00M | 118,00M |
| Current Assets | 4,46B | 3,98B | 4,49B | 3,99B | 3,84B |
| Current Liabilities | 3,23B | 2,80B | 2,68B | 2,22B | 2,31B |